Design and generation of humanized single-chain Fv derived from mouse hybridoma for potential targeting application

บทความในวารสาร


ผู้เขียน/บรรณาธิการ


กลุ่มสาขาการวิจัยเชิงกลยุทธ์

ไม่พบข้อมูลที่เกี่ยวข้อง


รายละเอียดสำหรับงานพิมพ์

รายชื่อผู้แต่งKhantasup K., Chantima W., Sangma C., Poomputsa K., Dharakul T.

ผู้เผยแพร่Mary Ann Liebert Inc.

ปีที่เผยแพร่ (ค.ศ.)2015

Volume number34

Issue number6

หน้าแรก404

หน้าสุดท้าย417

จำนวนหน้า14

นอก2167-9436

eISSN2167-9436

URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84951771744&doi=10.1089%2fmab.2015.0036&partnerID=40&md5=30a54aca77c7163cd42eedb38fc49059

ภาษาEnglish-Great Britain (EN-GB)


ดูบนเว็บไซต์ของสำนักพิมพ์


บทคัดย่อ

Single-chain variable antibody fragments (scFvs) are attractive candidates for targeted immunotherapy in several human diseases. In this study, a concise humanization strategy combined with an optimized production method for humanizing scFvs was successfully employed. Two antibody clones, one directed against the hemagglutinin of H5N1 influenza virus, the other against EpCAM, a cancer biomarker, were used to demonstrate the validity of the method. Heavy chain (VH) and light chain (VL) variable regions of immunoglobulin genes from mouse hybridoma cells were sequenced and subjected to the construction of mouse scFv 3-D structure. Based on in silico modeling, the humanized version of the scFv was designed via complementarity-determining region (CDR) grafting with the retention of mouse framework region (FR) residues identified by primary sequence analysis. Root-mean-square deviation (RMSD) value between mouse and humanized scFv structures was calculated to evaluate the preservation of CDR conformation. Mouse and humanized scFv genes were then constructed and expressed in Escherichia coli. Using this method, we successfully generated humanized scFvs that retained the targeting activity of their respective mouse scFv counterparts. In addition, the humanized scFvs were engineered with a C-terminal cysteine residue (hscFv-C) for site-directed conjugation for use in future targeting applications. The hscFv-C expression was extensively optimized to improve protein production yield. The protocol yielded a 20-fold increase in production of hscFv-Cs in E. coli periplasm. The strategy described in this study may be applicable in the humanization of other antibodies derived from mouse hybridoma. ฉ Mary Ann Liebert, Inc. 2015.


คำสำคัญ

ไม่พบข้อมูลที่เกี่ยวข้อง


อัพเดทล่าสุด 2023-28-09 ถึง 07:35